{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T09:09:49Z","timestamp":1777799389220,"version":"3.51.4"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Varices manifest as a major etiology of upper gastrointestinal bleeding in patients with chronic liver diseases, such as liver cirrhosis and hepatocellular carcinoma. By contrast, non-variceal upper gastrointestinal bleeding is rare. Pharmacological treatment differs between patients with variceal and non-variceal bleeding. Vasoconstrictors are recommended for the treatment of variceal bleeding, rather than non-variceal bleeding. In contrast, pump proton inhibitors are recommended for the treatment of non-variceal bleeding, rather than variceal bleeding. Herein, we present a case with liver cirrhosis and acute upper gastrointestinal bleeding who had a high risk of rebleeding (i.e., Child\u2013Pugh class C, hepatocellular carcinoma, portal vein thrombosis, low albumin, and high international normalized ratio and D-dimer). As the source of bleeding was obscure, only terlipressin without pump proton inhibitors was initially administered. Acute bleeding episode was effectively controlled. After that, an elective endoscopic examination confirmed that the source of bleeding was attributed to peptic ulcer, rather than varices. Based on this preliminary case report, we further discussed the potential role of vasoconstrictors in a patient with cirrhosis with acute non-variceal upper gastrointestinal bleeding.<\/jats:p>","DOI":"10.1515\/jtim-2017-0040","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T22:19:28Z","timestamp":1516313968000},"page":"240-244","source":"Crossref","is-referenced-by-count":2,"title":["Should vasoconstrictors be considered in a cirrhotic patient with acute non-variceal upper gastrointestinal bleeding?"],"prefix":"10.1515","volume":"5","author":[{"given":"Xingshun","family":"Qi","sequence":"first","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Shao","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Liang","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[{"name":"No. 4 People Hospital of Shenyang City , Shenyang 110031, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Feng","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Guo","sequence":"additional","affiliation":[{"name":"Liver Cirrhosis Study Group , Department of Gastroenterology, General Hospital of Shenyang Military Area , Shenyang , 110840, Liaoning Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"2023042508102939608_j_jtim-2017-0040_ref_001_w2aab3b7c10b1b6b1ab1b4b1Aa","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362: 823-32.10.1056\/NEJMra090151220200386","DOI":"10.1056\/NEJMra0901512"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_002_w2aab3b7c10b1b6b1ab1b4b2Aa","doi-asserted-by":"crossref","unstructured":"Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016; 15: 314-25.2704948510.5604\/16652681.1198800","DOI":"10.5604\/16652681.1198800"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_003_w2aab3b7c10b1b6b1ab1b4b3Aa","unstructured":"Peng Y, Qi X, Dai J, Li H, Guo X. Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med 2015; 8: 751-7.25785053"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_004_w2aab3b7c10b1b6b1ab1b4b4Aa","doi-asserted-by":"crossref","unstructured":"Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turk J Gastroenterol 2016; 27: 180-6.2701562310.5152\/tjg.2016.15502","DOI":"10.5152\/tjg.2016.15502"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_005_w2aab3b7c10b1b6b1ab1b4b5Aa","doi-asserted-by":"crossref","unstructured":"Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015; 64: 1680-704.2588738010.1136\/gutjnl-2015-309262","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_006_w2aab3b7c10b1b6b1ab1b4b6Aa","doi-asserted-by":"crossref","unstructured":"Gabr MA, Tawfik MA, El-Sawy AA. Non-variceal upper gastrointestinal bleeding in cirrhotic patients in Nile Delta. Indian J Gastroenterol 2016; 35: 25-32.2688412510.1007\/s12664-016-0622-7","DOI":"10.1007\/s12664-016-0622-7"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_007_w2aab3b7c10b1b6b1ab1b4b7Aa","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gonzalez JA, Garcia-Compean D, Vazquez-Elizondo G, Garza-Galindo A, Jaquez-Quintana JO, Maldonado-Garza H. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Ann Hepatol 2011; 10: 287-95.","DOI":"10.1016\/S1665-2681(19)31540-6"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_008_w2aab3b7c10b1b6b1ab1b4b8Aa","unstructured":"de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-52.2604790810.1016\/j.jhep.2015.05.022"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_009_w2aab3b7c10b1b6b1ab1b4b9Aa","doi-asserted-by":"crossref","unstructured":"Sun R, Qi X, Zou D, Shao X, Li H, Guo X. Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis. AME Med J 2017; 2: 39.","DOI":"10.21037\/amj.2017.03.03"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_010_w2aab3b7c10b1b6b1ab1b4c10Aa","doi-asserted-by":"crossref","unstructured":"Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol 2012; 57: 1207-13.10.1016\/j.jhep.2012.07.03822885718","DOI":"10.1016\/j.jhep.2012.07.038"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_011_w2aab3b7c10b1b6b1ab1b4c11Aa","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65: 310-35.10.1002\/hep.28906","DOI":"10.1002\/hep.28906"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_012_w2aab3b7c10b1b6b1ab1b4c12Aa","doi-asserted-by":"crossref","unstructured":"Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 345-60; quiz 61.2231022210.1038\/ajg.2011.480","DOI":"10.1038\/ajg.2011.480"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_013_w2aab3b7c10b1b6b1ab1b4c13Aa","doi-asserted-by":"crossref","unstructured":"Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, et al. Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut 2011; 60: 1170-7.10.1136\/gut.2010.230292","DOI":"10.1136\/gut.2010.230292"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_014_w2aab3b7c10b1b6b1ab1b4c14Aa","doi-asserted-by":"crossref","unstructured":"Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002; 51(Suppl 4): iv1-6.12208839","DOI":"10.1136\/gut.51.suppl_4.iv1"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_015_w2aab3b7c10b1b6b1ab1b4c15Aa","doi-asserted-by":"crossref","unstructured":"Jenkins SA, Poulianos G, Coraggio F, Rotondano G. Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding. Dig Dis 1998; 16: 214-24.10.1159\/0000168699732181","DOI":"10.1159\/000016869"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_016_w2aab3b7c10b1b6b1ab1b4c16Aa","doi-asserted-by":"crossref","unstructured":"Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med 1997; 127: 1062-71.941230810.7326\/0003-4819-127-12-199712150-00002","DOI":"10.7326\/0003-4819-127-12-199712150-00002"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_017_w2aab3b7c10b1b6b1ab1b4c17Aa","doi-asserted-by":"crossref","unstructured":"Greenspoon J, Barkun A. The pharmacological therapy of non-variceal upper gastrointestinal bleeding. Gastroenterol Clin North Am 2010; 39: 419-32.10.1016\/j.gtc.2010.08.00220951910","DOI":"10.1016\/j.gtc.2010.08.002"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_018_w2aab3b7c10b1b6b1ab1b4c18Aa","doi-asserted-by":"crossref","unstructured":"Choi CW, Kang DH, Kim HW, Park SB, Park KT, Kim GH, et al. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J Gastroenterol 2011; 17: 3441-7.2187663610.3748\/wjg.v17.i29.3441","DOI":"10.3748\/wjg.v17.i29.3441"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_019_w2aab3b7c10b1b6b1ab1b4c19Aa","doi-asserted-by":"crossref","unstructured":"May G, Butler J. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. The use of vasoconstrictor therapy in non-variceal upper GI bleeds. Emerg Med J. 2006; 23: 722-4.10.1136\/emj.2006.040162","DOI":"10.1136\/emj.2006.040162"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_020_w2aab3b7c10b1b6b1ab1b4c20Aa","unstructured":"Saruc M, Can M, Kucukmetin N, Tuzcuoglu I, Tarhan S, Goktan C, et al. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study. Med Sci Monit 2003; 9: PI84-7.12883463"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_021_w2aab3b7c10b1b6b1ab1b4c21Aa","doi-asserted-by":"crossref","unstructured":"Avgerinos A, Sgouros S, Viazis N, Vlachogiannakos J, Papaxoinis K, Bergele C, et al. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial. Scand J Gastroenterol 2005; 40: 515-22.10.1080\/0036552051001545816036503","DOI":"10.1080\/00365520510015458"},{"key":"2023042508102939608_j_jtim-2017-0040_ref_022_w2aab3b7c10b1b6b1ab1b4c22Aa","doi-asserted-by":"crossref","unstructured":"Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004; 59: 993-1001.1548805910.1111\/j.1365-2044.2004.03877.x","DOI":"10.1111\/j.1365-2044.2004.03877.x"}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/jtim\/5\/4\/article-p240.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2017-0040\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2017-0040\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T08:20:16Z","timestamp":1682410816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2017-0040\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12,29]]},"published-print":{"date-parts":[[2017,12,29]]}},"alternative-id":["10.1515\/jtim-2017-0040"],"URL":"https:\/\/doi.org\/10.1515\/jtim-2017-0040","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}